Tag: insulin delivery devices market research

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Insulin Delivery Devices Market?

The insulin delivery devices market is anticipated to grow, fueled by the escalating occurrences of diabetes. Diabetes, a long-term disease distinguished by high levels of sugar in the blood, is primarily caused by either insufficient insulin production or the body’s inefficiency to use insulin effectively. The increase in diabetes is predominantly attributed to factors such as inactive lifestyles, poor eating habits, and the global surge in obesity. Insulin delivery devices play a vital role in assisting individuals with diabetes to regulate their blood sugar effectively. These devices allow for monitored and convenient administration of insulin, thereby averting complications and promoting general health. The Centers for Disease Control and Prevention, a US government agency, revealed in December 2022, that the count of young individuals under 20 with type 2 diabetes could escalate by nearly 700% by 2060 in the United States, potentially impacting 220,000 individuals. Concurrently, diagnoses of type 1 diabetes among young individuals could increase by up to 65%. Thus, the insulin delivery devices market expansion is being driven by the rising prevalence of diabetes.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

#What is the Anticipated CAGR of theInsulin Delivery Devices Market, and What Factors Will Drive It?

The market size for insulin delivery devices has seen strong growth in the last few years, expanding from $17.71 billion in 2024 to an estimated $19.22 billion in 2025. This represents a compound annual growth rate (CAGR) of 8.5%. The historical growth pattern can be ascribed to several factors, including the convenience and simplicity of insulin delivery devices, favorable reimbursement policies, a rising incidence of obesity, an increasingly aging population, and a higher uptake of insulin pumps.

Strong expansion is anticipated in the insulin delivery devices market in the forthcoming years, with the market projected to reach a value of $26.3 billion by 2029, growing at an 8.2% compound annual growth rate (CAGR). The predicted growth during this period stems from the increasing number of diabetes patients, elevated spending on diabetes care, the emergence of continuous glucose monitoring systems, heightened patient awareness about the advantages of automated insulin delivery devices, and an intensified focus on healthcare. Notable forecast period trends encompass technological improvements in insulin delivery devices, incorporation of digital technology into these devices, the evolution of artificial pancreas systems, enhancements in insulin administration technology, and progress in bionic technology.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642

What Are the Key Market Innovations in theInsulin Delivery Devices Market Over the Coming Years?

Leading firms in the insulin delivery devices market are leveraging innovation to produce products like insulin pumps that deliver insulin in a continuous or customizable fashion. An insulin pump, a programmable medical device, delivers insulin on a continuous basis or as needed via a catheter inserted beneath the skin. For example, in May of 2023, Beta Bionics, an American medical tech company, received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and the iLet Dosing Decision Software. The iLet Bionic Pancreas system is meant to assist individuals aged six or older diagnosed with type 1 diabetes by merging two devices with an FDA-approved integrated continuous glucose monitor (iCGM). It is designed to function on an automated insulin dosing (AID) system controlled by an adaptive closed-loop algorithm that initially requires only the user’s body weight for setup and gets rid of the need for additional insulin dosing parameters. This system differs from traditional pump therapy as it doesn’t require manual adjustment of settings, thereby making it simpler to start and operate. The iLet device also introduces a feature that simplifies insulin dosing during meals by classifying meals as small, medium, or large. Over time, the algorithm learns and adjusts to individual insulin needs.

Who Are the Top Companies Driving Innovation and Growth in theInsulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Key Market Segments Comprise the Insulin Delivery Devices Market and Drive Its Revenue Growth?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Which Regions Are Emerging as Leaders in the Insulin Delivery Devices Market?

North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2025, By The Business Research Company:

Insulin biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-biosimilars-global-market-report

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

Insulin Patch Pumps Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the insulin delivery devices market size evolved in recent years?

The size of the insulin delivery devices market has seen consistent expansion in the recent past. Rising from $17.71 billion in 2024 to $19.22 billion in 2025, it presents a compound annual growth rate (CAGR) of 8.5%. Reasons underpinning this growth in the historical timeline include the comfort and simplicity provided by insulin delivery devices, positive compensation policies, surging obesity rates, an ageing population, and the growing use of insulin pumps.

What are the predictions for the insulin delivery devices market size in the coming years?

The market for insulin delivery devices is projected to witness robust expansion in the coming years, reaching a valuation of $26.3 billion in 2029, expanding at a compound annual growth rate (CAGR) of 8.2%. The surge during the forecast period can be credited to the increasing frequency of diabetes, rising expenditure on diabetes care, the adoption of continuous glucose monitoring systems, heightened patient awareness about the advantages of automated insulin delivery devices, and a heightened emphasis on healthcare. Key trends during the forecast period will encompass advancements in insulin delivery devices technology, digital technology integration with insulin delivery devices, progress in the creation of artificial pancreas systems, innovations in insulin administration technology, and advancements in bionic technology.

Get your insulin delivery devices market report here!

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

What key factors are fueling the growth of the insulin delivery devices market?

The surge in diabetes cases is anticipated to fuel the insulin delivery devices market’s expansion in the future. Characterized by heightened blood sugar levels due to insufficient insulin production or the body’s failure to adequately absorb insulin, diabetes is a long-term ailment. The rise in diabetes can be attributed to inactive lifestyles, poor eating habits, and an increase in obesity rates worldwide. Insulin delivery devices are necessary for managing diabetes as they allow people to control their blood sugar levels in a convenient, regulated manner, hence preventing any adverse effects and promoting overall well-being. In line with this, data from the Centers for Disease Control and Prevention in December 2022 suggests that the count of people below 20 years of age with type 2 diabetes in the U.S. could see a staggering 700% increase by 2060, potentially affecting around 220,000 individuals. Simultaneously, type 1 diabetes diagnoses among the youth could surge by up to 65% during the same timeline. Consequently, the escalating number of diabetes cases is catalyzing the growth of the insulin delivery devices market.

How is the global insulin delivery devices market divided into key segments?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

Who are the key firms paving the way for growth in the insulin delivery devices market?

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

What are the key trends shaping the future of the insulin delivery devices market?

Leading businesses in the insulin delivery devices marketplace are creating advanced products such as insulin pumps, designed to administer insulin steadily or as necessary. These insulin pumps are interactive medical gadgets that dispense insulin consistently through a catheter implanted beneath the skin. For example, Beta Bionics, a medical tech corporation from the United States, came forward in May 2023 with U.S. Food and Drug Administration approval for its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system, intended for people aged six and above who have type 1 diabetes, is a combination of two devices equipped with a fitting FDA-certified integrated continuous glucose monitor (iCGM). This system functions through an automated insulin dosing (AID) mechanism that is controlled by an adjusting closed-loop algorithm which initially uses only the user’s body weight for the setup and removes the necessity for additional insulin dosing specifics. Contrary to traditional pump treatments, this system doesn’t require manual modification of configurations, making it simpler to start and manage. The iLet instrument also features a meal announcement feature that streamlines mealtime insulin dosing by categorizing meals into three sizes: small, medium or large. The system’s algorithm also learns and adjusts to individual insulin needs over time.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642

What regions are contributing significantly to the growth of the insulin delivery devices market?

North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Insulin biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-biosimilars-global-market-report

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

Insulin Patch Pumps Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Long-Term Growth Rate is Expected for the Insulin Delivery Devices Market Between 2025 and 2034?

The market size of insulin delivery devices has seen considerable expansion in the recent past. It is projected to escalate from $17.71 billion in 2024 to a staggering $19.22 billion in 2025, posting a compound annual growth rate (CAGR) of 8.5%. This growth during the historic period is attributed to factors such as the convenience and user-friendliness of insulin delivery devices, encouraging reimbursement policies, rising obesity rates, an aging population, and increased adoption of insulin pumps.

There is an expected solid expansion of the insulin delivery devices market in the upcoming years. It is projected to escalate to $26.3 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.2%. This growth during the forecast period is believed to be due to factors such as increasing prevalence of diabetes, rising healthcare costs associated with diabetes management, the emergence of continuous glucose monitoring systems, improved patient awareness about the advantages of automatic insulin delivery devices, and a heightened focus on healthcare. Future trends during this period include advancements in the technology of insulin delivery devices, digital technology integration with these devices, the creation of artificial pancreas systems, developments in insulin delivery methods, and progressive bionic technology.

What Key Drivers Are Accelerating the Growth of the Insulin Delivery Devices Market During the Forecast Period?

The escalation in diabetes instances is predicted to stimulate the expansion of the insulin delivery devices market in the future. Diabetes, a chronic condition characterized by elevated blood sugar levels, results from insufficient insulin production by the pancreas or the body’s failure to use insulin effectively. The soaring rates of this disease are mainly attributable to inactive lifestyles, poor eating habits, and a global increase in obesity. Insulin delivery devices, which provide a regulated and convenient way to administer insulin, are necessary for managing diabetes, as they help to maintain blood sugar levels, avert complications, and promote overall well-being. For example, the Centers for Disease Control and Prevention, a US governmental agency, reported in December 2022 that the instances of type 2 diabetes in individuals below 20 years in the US could surge by almost 700% by 2060, reaching approximately 220,000 individuals. In the same time span, diagnoses of type 1 diabetes in young people could potentially increase by 65%. Consequently, the mounting prevalence of diabetes is fueling the growth of the insulin delivery devices market.

Explore Comprehensive Insights Into The Global Insulin Delivery Devices Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Are the Key Firms That Are Driving Transformation in the Insulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are:

• Sanofi SA_x000D_

• Abbott Laboratories_x000D_

• F. Hoffmann-La Roche Ltd._x000D_

• Medtronic Plc_x000D_

• Eli Lilly and Company_x000D_

What Current Trends in the Insulin Delivery Devices Market Should Industry Players Pay Attention To?

Key players in the insulin delivery devices market are concentrating their efforts on developing innovative products like insulin pumps, which allow for constant or tailor-made insulin delivery. These insulin pumps are technologically advanced, programmable devices that administer insulin consistently or if needed via a catheter inserted under the skin. For example, Beta Bionics, a medical tech firm based in the US, received FDA approval for the iLet ACE Pump and iLet Dosing Decision Software in May 2023. The iLet Bionic Pancreas system, designed for people six years and above diagnosed with type 1 diabetes, pairs two devices with a compatible FDA-cleared built-in continuous glucose monitor (iCGM). This system functions on an automated insulin dosage (AID) model guided by a responsive closed-loop algorithm that only necessitates using the user’s bodyweight during setup, effectively nullifying the need for extra insulin dosage guidelines. Distinct from conventional pump therapy, this system doesn’t require any manual adjustment to the configuration which simplifies initiation and maintenance. The iLet device further unveils a meal notification feature that facilitates mealtime insulin dosing by classifying meals into small, medium, or large. Consequently, the algorithm learns and adjusts to individual insulin needs over time.

Secure Your Global Insulin Delivery Devices Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

What Are the Strategic Segments Comprising the Insulin Delivery Devices Market and Their Growth Contributions?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

What Regions Are Driving Expansion in the Insulin Delivery Devices Market?

North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does the Definition of the Insulin Delivery Devices Market Include?

Insulin delivery devices refer to medical tools designed to administer insulin into the body of a person with diabetes. These devices are crucial for managing blood glucose levels in individuals who cannot produce sufficient insulin naturally. These devices are used to manage blood sugar levels effectively, providing flexibility and convenience in insulin administration.

Browse Through More Similar Reports By The Business Research Company:

Insulin biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-biosimilars-global-market-report

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

Insulin Patch Pumps Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Will Be the Growth Trajectory of the Insulin Delivery Devices Market from 2024 to 2033?

The insulin delivery devices market will grow from $16.38 billion in 2023 to $17.71 billion in 2024, with a CAGR of 8.1%. This growth can be attributed to the convenience of insulin devices and increasing prevalence of obesity.

The insulin delivery devices market is expected to see strong growth in the next few years. It is anticipated to grow to $24.32 billion by 2028, with a CAGR of 8.3%. This growth is linked to the increasing prevalence of diabetes, rising healthcare expenditures on diabetes care, the emergence of continuous glucose monitoring systems, growing patient awareness of the benefits of automated insulin delivery devices, and a focus on healthcare. Major trends include advancements in insulin delivery technologies, the integration of digital technologies with these devices, the development of artificial pancreas systems, improvements in insulin administration technology, and advancements in bionic technology.

What Are the Primary Growth Drivers for the Insulin Delivery Devices Market?

The increasing prevalence of diabetes is expected to drive the insulin delivery device market. The rise in diabetes cases, due to factors like unhealthy diets, sedentary lifestyles, and obesity, necessitates insulin delivery devices to help individuals manage their blood sugar levels effectively.

Claim Your Free Sample of the Global Insulin Delivery Devices Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Are the Defining Segments of the Insulin Delivery Devices Market?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps
2) By Disease Indication: Type 1, Type 2
3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centres

What Trends Are Revolutionizing Standards in the Insulin Delivery Devices Market?

Major companies in the insulin delivery device market are advancing the development of products like insulin pumps to offer continuous or customizable insulin delivery. Insulin pumps are programmable devices that deliver insulin through a catheter placed under the skin.

Order Now for Fast Delivery of Your Insulin Delivery Devices Market Report!

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

What Regions Are Propelling Growth in the Insulin Delivery Devices Industry?

North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Insulin Delivery Devices Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the insulin delivery devices market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Insulin Delivery Devices Market Include

1. Insulin Delivery Devices Market Executive Summary
2. Insulin Delivery Devices Market Segments
3. Insulin Delivery Devices Market Size And Template Market Growth Rate
4.  Key Insulin Delivery Devices Market Trends
5. Major Insulin Delivery Devices Market Drivers
……
25. Key Mergers And Acquisitions In The Insulin Delivery Devices Market
26. Top Insulin Delivery Devices Companies
27. Insulin Delivery Devices Market Opportunities And Strategies
28. Insulin Delivery Devices Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:

Insulin Pens, Syringes, Pumps And Injectors Market 2024

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market

Insulin Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/sample_request?id=2674&type=smp

Smart Insulin Pens Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The insulin delivery devices market size has demonstrated strong growth in recent years, expected to grow from $16.38 billion in 2023 to $17.71 billion in 2024, reflecting a compound annual growth rate (CAGR) of 8.1%. This growth in the historic period can be attributed to the convenience and ease of use offered by insulin delivery devices, favorable reimbursement policies, an increasing prevalence of obesity, a growing aging population, and a rise in the adoption of insulin pumps. Looking ahead, the market size is projected to reach $24.32 billion in 2028, with a CAGR of 8.3%. The expected growth in the forecast period can be linked to the growing prevalence of the diabetic population, increased healthcare expenditure on diabetes care, the rise of continuous glucose monitoring systems, enhanced patient awareness regarding the benefits of automated insulin delivery devices, and a heightened focus on healthcare. Major trends anticipated include technological advancements in insulin delivery devices, the integration of digital technology, the development of artificial pancreas systems, advancements in insulin administration technology, and innovations in bionic technology.

The growing prevalence of diabetes is projected to drive the growth of the insulin delivery device market in the coming years. Diabetes is characterized by elevated blood sugar levels, which can be caused by insufficient insulin production or the body’s inability to effectively utilize insulin. The rising incidence of diabetes is primarily linked to sedentary lifestyles, unhealthy diets, and increasing obesity rates worldwide. Insulin delivery devices play a critical role in diabetes management by enabling individuals to administer insulin in a controlled and convenient manner, thus preventing complications and promoting better health. For instance, according to the Centers for Disease Control and Prevention in December 2022, the number of young people under 20 with type 2 diabetes in the U.S. could increase by nearly 700% by 2060, potentially reaching 220,000 individuals. Simultaneously, diagnoses of type 1 diabetes among young people could rise by as much as 65% over the same period. Therefore, the growing prevalence of diabetes is driving the growth of the insulin delivery device market through 2023, into 2024, and is anticipated to continue expanding by 2028.

Get A Free Sample On The Insulin Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Are The Key Trends That Influence Insulin Delivery Devices Market Share Analysis?

Major companies in the insulin delivery device market are focused on developing innovative products, such as insulin pumps, to provide continuous or customizable insulin delivery. Insulin pumps are programmable medical devices that deliver insulin continuously or as required through a catheter placed under the skin. For example, in May 2023, Beta Bionics, a US-based medical technology company, announced FDA approval for the iLet ACE Pump and the iLet Dosing Decision Software. The iLet Bionic Pancreas system is designed for individuals aged six and older with type 1 diabetes, combining two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). It operates using an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which initially requires only the user’s body weight for setup, eliminating the need for additional insulin dosing parameters. Unlike traditional pump therapy, this system does not require manual adjustment of settings, simplifying initiation and management. The iLet device also features a meal announcement capability that streamlines mealtime insulin dosing by categorizing meals as small, medium, or large, while the algorithm learns and adapts to individual insulin needs over time.

Which Market Players Are Driving Growth In The Insulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

How Is The Global Insulin Delivery Devices Market Segmented?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps
2) By Disease Indication: Type 1, Type 2
3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centres

Read The Full Insulin Delivery Devices Market Report Here

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

The Insulin Delivery Devices Global Market Report 2024 provides an overview of the insulin delivery devicesmarket for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The insulin delivery devices market forecast analyzes insulin delivery devices market size, insulin delivery devices market share, leading competitor and their market positions.

The Table Of Content For The Insulin Delivery Devices Market Include

1. Insulin Delivery Devices Market Executive Summary
2. Insulin Delivery Devices Market Segments
3. Insulin Delivery Devices Market Size And Template Market Growth Rate
4.  Key Insulin Delivery Devices Market Trends
5. Major Insulin Delivery Devices Market Drivers
……
25. Key Mergers And Acquisitions In The Insulin Delivery Devices Market
26. Top Insulin Delivery Devices Companies
27. Insulin Delivery Devices Market Opportunities And Strategies
28. Insulin Delivery Devices Market, Conclusions And Recommendations
29. Appendix

Explore Similar Reports From The Business Research Company:

Insulin Pens, Syringes, Pumps And Injectors Market 2024

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market

Insulin Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/sample_request?id=2674&type=smp

Smart Insulin Pens Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model